Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Sieviläinen, Meri
32  Ergebnisse:
Personensuche X
?
1

Evaluation of in vitro and in vivo personalized cancer trea..:

Wahbi, Wafa ; Korelin, Katja ; Sieviläinen, Meri...
Translational Oncology.  33 (2023)  - p. 101677 , 2023
Link: https://doi.org/10.1016/..
 
?
2

IDO1 Inhibition Reduces Immune Cell Exclusion Through Induc..:

Sieviläinen, Meri ; Saavalainen, Jordan ; Adnan-Awad, Shady..
Frontiers in Immunology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
3

Evaluation Challenges in the Validation of B7-H3 as Oral To..:

Sieviläinen, Meri ; Wirsing, Anna Maria ; Hyytiäinen, Aini...
Head and Neck Pathology.  15 (2020)  2 - p. 469-478 , 2020
Link: https://doi.org/10.1007/..
 
?
4

Prognostic value of blood and lymphatic vessel markers in t..:

Almahmoudi, Rabeia ; Kasanen, Merimaija ; Sieviläinen, Meri...
Cancer Science.  110 (2019)  11 - p. 3424-3433 , 2019
Link: https://doi.org/10.1111/..
 
?
5

Extracellular interleukin‐17F has a protective effect in or..:

Almahmoudi, Rabeia ; Salem, Abdelhakim ; Sieviläinen, Meri...
Head & Neck.  40 (2018)  10 - p. 2155-2165 , 2018
Link: https://doi.org/10.1002/..
 
?
6

The prognostic value of immune checkpoints in oral squamous..:

Sieviläinen, Meri ; Almahmoudi, Rabeia ; Al‐Samadi, Ahmed...
Oral Diseases.  25 (2018)  6 - p. 1435-1445 , 2018
Link: https://doi.org/10.1111/..
 
?
7

Immune checkpoints indoleamine 2,3‐dioxygenase 1 and progra..:

Sieviläinen, Meri ; Passador‐Santos, Fabricio ; Almahmoudi, Rabeia...
Journal of Oral Pathology & Medicine.  47 (2018)  8 - p. 773-780 , 2018
Link: https://doi.org/10.1111/..
 
?
8

IMMUNE CHECKPOINTS INDOLEAMINE 2,3-DIOXYGENASE 1 AND PROGRA..:

SievilÄinen, Ms. Meri ; Passador-Santos, Dr. Fabricio ; Almahmoudi, Ms. Rabeia...
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.  128 (2019)  1 - p. e25 , 2019
Link: https://doi.org/10.1016/..
 
?
9

Evaluation of in vitro and in vivo personalized cancer trea..:

Wahbi, Wafa ; Korelin, Katja ; Sieviläinen, Meri...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182324/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
10

Evaluation of in vitro and in vivo personalized cancer trea..:

Wahbi, Wafa ; Korelin, Katja ; Sieviläinen, Meri...
10.1016/j.tranon.2023.101677.  , 2023
Link: http://hdl.handle.net/10..
 
?
11

Evaluation Challenges in the Validation of B7-H3 as Oral To..:

Sieviläinen, Meri ; Wirsing, Anna Maria ; Hyytiäinen, Aini...
10.1007/s12105-020-01222-3.  , 2023
Link: http://hdl.handle.net/10..
 
?
12

IDO1 Inhibition Reduces Immune Cell Exclusion Through Induc..:

Sieviläinen, Meri ; Saavalainen, Jordan ; Adnan-Awad, Shady..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963946/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
13

IDO1 Inhibition Reduces Immune Cell Exclusion Through Induc..:

Sieviläinen, Meri ; Saavalainen, Jordan ; Adnan-Awad, Shady..
10.3389/fimmu.2022.812822.  , 2022
Link: http://hdl.handle.net/10..
 
?
14

Evaluation Challenges in the Validation of B7-H3 as Oral To..:

Sieviläinen, Meri ; Wirsing, Anna Maria ; Hyytiäinen, Aini...
15.  , 2021
Link: https://trepo.tuni.fi/ha..
 
?
15

Evaluation Challenges in the validation of B7-H3 as oral to..:

Sieviläinen, Meri ; Wirsing, Anna Maria ; Hyytiäinen, Aini...
Head and Neck Pathology.  , 2020
Link: https://hdl.handle.net/1..
 
1-15